Infection Burden and Survival Outcomes in Multiple Myeloma Patients with Acquired Hypogammaglobulinemia Receiving Antibiotic Prophylaxis without IVIG: A Single-Center Real-World Study
Abstract
Infections remain one of the leading causes of morbidity and mortality in patients with multiple myeloma (MM), particularly during the first three months following diagnosis. This study specifically aimed to evaluate the infection burden and survival outcomes in MM patients with acquired hypogammaglobulinemia receiving antibiotic prophylaxis alone. This retrospective single-center study included 22 MM patients diagnosed with acquired hypogammaglobulinemia between January 2020 and December 2022. Hypogammaglobulinemia was defined as IgG < 500 mg/dL (excluding paraproteins). Patients received levofloxacin prophylaxis for the first 3 months after diagnosis, followed by trimethoprim/sulfamethoxazole and valacyclovir throughout the treatment process. The median age was 66.9 years (range: 53-88), and 63.6% of patients were ≥65 years old and 59.1% of the patients were male. A total of 43 infections were recorded, with pneumonia being the most common (30.2%). Only 4 patients (18.2%) required hospitalization due to infection, and 2 patients (9.1%) had neutropenia during the infection period. The median overall survival (OS) was 22 months (range: 1-85), with 7 deaths (31.8%) recorded, and only 1 (4.5%) was infection-related. Patients with light chain myeloma had a higher incidence of infections compared to other myeloma types (p= 0.02). Hospitalization due to infection was associated with shorter OS (p= 0.002). Our findings suggest that antibiotic prophylaxis may help limit severe…
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets
- Molecular Epidemiology of mcr-1 -Positive Polymyxin B-Resistant Escherichia coli Producing Extended-Spectrum β-Lactamase (ESBL) in a Tertiary Hospital in Shandong, China
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.